Enzyme‐Activated Programmable Theranostic Platform for Spatiotemporal Imaging of Intracellular MicroRNA and On‐Demand Manipulation‐Mediated Therapy
Small · 2026-03 · 22 (17)
DOI: 10.1002/smll.202512828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 25.01.2026. Verfasst von Xiangdan Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory For Bioengineering and Sensing Technology, Research Center for Bioengineering and Sensing Technology, School of Chemistry and …. Hauptthemen laut MEDLINE: MicroRNAs, Theranostic Nanomedicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Medical Research Fund, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Imaging the aberrant expression of a single microRNA (miRNA) in living cells is often inadequate for accurately evaluating pathological states or implementing responsive therapies. It is a critical need for advanced molecular tools capable of spatiotemporally sensing miRNA and other biomarkers, accompanying the on‐demand therapeutic functions. Here, we present a miRNA molecular strategy, enabling both biomarker detection and biomarker‐driven therapy. In this platform, a Cy3‐labeled hairpin reporter (EH1) containing an apurinic/apyrimidinic endonuclease 1 (APE1) recognition unit, along with a Cy5‐labeled hairpin (H2), is co‐loaded onto the cerium‐based metal–organic framework (Ce‐MOF) in a precisely controlled manner (Ce‐MOF/DNA). Upon internalization in tumor cells characterized by the elevated levels of carcinogenic APE1 and miRNA‐21, the Ce‐MOF/DNA theranostic system is activated. APE1 and miRNA‐21 function as endogenous activators that trigger the hybridization chain reaction (HCR), leading to fluorescent resonance energy transfer (FRET) between Cy3 and Cy5, which provides a reliable readout for evaluating disease conditions in real‐time. Moreover, the Ce‐MOF/DNA system exerts therapeutic effects by upregulating the tumor suppressor gene PTEN and inhibiting the oncogenic functions of miRNA‐21, thereby suppressing tumor growth. This approach may pave the way for precise diagnosis and effective treatment for cancers characterized by dysregulated miRNA expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory For Bioengineering and Sensing Technology, Research Center for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing,…
- School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, P. R. China.
- Basic Medical College, Shanxi Medical University, Taiyuan, P. R. China.
- Marshall Laboratory of Biomedical Engineering, Precision Medicine and Health Research Institute, Shenzhen Key Laboratory For Nano-Biosensing Technology, School of Biomedical Engineering, Shenzhen University, Guangdong,…
ORCID-Profile: Haifeng Dong
Förderung
- National Natural Science Foundation of China
- Shenzhen Medical Research Fund
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Meng, X., Pang, X., Sun, S., An, H., Yang, F., Zhang, X., & Dong, H. (2026). Enzyme‐Activated Programmable Theranostic Platform for Spatiotemporal Imaging of Intracellular MicroRNA and On‐Demand Manipulation‐Mediated Therapy. Small, 22(17). https://doi.org/10.1002/smll.202512828
Vancouver
Meng X, Pang X, Sun S, An H, Yang F, Zhang X, et al. Enzyme‐Activated Programmable Theranostic Platform for Spatiotemporal Imaging of Intracellular MicroRNA and On‐Demand Manipulation‐Mediated Therapy. Small. 2026;22(17). doi:10.1002/smll.202512828
BibTeX
@article{Meng2026,
author = {Meng, Xiangdan and Pang, Xuejiao and Sun, Sirong and An, Heng and Yang, Fan and Zhang, Xueji and Dong, Haifeng},
title = {Enzyme‐Activated Programmable Theranostic Platform for Spatiotemporal Imaging of Intracellular MicroRNA and On‐Demand Manipulation‐Mediated Therapy},
journal = {Small},
year = {2026},
volume = {22},
number = {17},
doi = {10.1002/smll.202512828}
}
EUVIMED